Related Experiment Video
Updated: Feb 10, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Multidrug resistance in Gram-negative pathogens isolated from patients with chronic kidney diseases and renal
Bushra Jamil1, Mohammad Tauseef Mukhtar Bokhari2, Azhar Saeed2
1National University of Medical Sciences, Rawalpindi.
Abstract:
Multidrug resistance (MDR) in gram-negative pathogens is the emerging threat to clinicians. The current study was designed to determine the prevalence and pattern of multidrug resistance in gram-negative clinical isolates. It was conducted at the COMSATS Institute of Information Technology, Islamabad, Pakistan, from June to October 2014. Of the 8, 300 samples collected, 729(8.8%) clinically important gram-negative pathogens were retrieved. These pathogens were subjected to phenotypic and biochemical detection and were further processed for multidrug resistance pattern. It was observed that gram-negative pathogens were simultaneously resistant to many antibiotics. The prevalence of extended spectrum b-lactamase phenomenon was 220(100%) in Klebsiella pneumoniae, 195(75%) in Escherichia coli. Resistance to carbapenem was 174(79%) in Klebsiella pneumoniae and 14(5.4%) in Escherichia coli. Resistance against fluoroquinolones also displayed an escalating trend. The current study found that resistance against antibiotics was displaying a drastic increase in chronic renal patients.
Insights
Multidrug resistance in gram-negative pathogens is a growing clinical concern. This study found high rates of antibiotic resistance, particularly in chronic renal patients, highlighting an urgent need for effective treatment strategies.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Multidrug resistance (MDR) in gram-negative pathogens poses a significant threat to clinical practice.
- The increasing prevalence of MDR necessitates understanding resistance patterns in local isolates.
Purpose of the Study:
- To determine the prevalence and patterns of multidrug resistance in gram-negative clinical isolates.
- To investigate the antibiotic resistance trends in specific gram-negative bacteria.
Main Methods:
- Collection and processing of 8,300 clinical samples from June to October 2014.
- Isolation and identification of 729 clinically significant gram-negative pathogens.
- Phenotypic, biochemical, and antimicrobial resistance pattern analysis.
Main Results:
- High prevalence of extended-spectrum beta-lactamase (ESBL) production: 100% in Klebsiella pneumoniae and 75% in Escherichia coli.
- Significant carbapenem resistance observed: 79% in K. pneumoniae and 5.4% in E. coli.
- Escalating resistance trends against fluoroquinolones and a drastic increase in antibiotic resistance among chronic renal patients.
Conclusions:
- Gram-negative pathogens exhibit simultaneous resistance to multiple antibiotics.
- The study highlights a concerning rise in antibiotic resistance, especially in vulnerable patient groups like those with chronic renal conditions.
- Urgent interventions are required to combat the escalating threat of multidrug-resistant gram-negative infections.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Gram-negative Bacterial Protein Secretion Systems
Kidney Transplant I: Introduction

